Silo Pharma, Inc. — Form 8-K
Filed August 17, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 62/100
What the filing says
Silo Pharma filed a Certificate of Amendment to its Articles of Incorporation on 2024-03-02, increasing total authorized shares to 255,000,000 (250M common at $0.0001 par, 5M preferred at $0.0001 par). The amendment was approved by stockholders holding majority voting power. No dollar amounts, issuance details, or dilution specifics are disclosed in this administrative filing.
Why this rating
Share authorization increase is material relative to $5.3M market cap—signals potential heavy dilution ahead. Administrative in form but strategically significant for shareholder base.
See more from August 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.